510(k) K212915
K212915 is an FDA 510(k) premarket notification submitted by MVision AI for the device "MVision AI Segmentation". The FDA issued a decision of Substantially Equivalent on May 3, 2022. The device falls under product code QKB (Radiological Image Processing Software For Radiation Therapy), a Class II device regulated under 21 CFR 892.2050. MVision AI has 2 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 3, 2022
- Date Received
- Sep 13, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Radiological Image Processing Software For Radiation Therapy
- Device Class
- Class II
- Regulation Number
- 892.2050
- Review Panel
- RA
- Submission Type
- 510(k)
To provide semi-automatic or fully-automated radiological image processing and analysis tools for radiation therapy. Software implementing artificial intelligence (AI) including nonadaptive machine learning algorithms trained with clinical and/or artificial radiological images. In these devices, the algorithm training images typically impact device performance. AI based radiological image processing software is intended to be used in the workflow of radiation therapy. Adaptive AI algorithms are not within the scope of this product code. Primary radiation dose calculation or plan optimization for treatment planning are not within scope of this product code.
Need the full FDA record for MVision AI? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.